IBM Stocks Fall Although Morgan Stanley Raises Target 25%
IBM shares fell 1.08% to $231.59 despite Morgan Stanley raising its price target to $238 from $190, citing infrastructure strength. Q2 results showed $2.5B in free cash flow, with dividends consuming 64%. Software revenue grew 5% to $7.8B, while consulting revenue remained flat at $5.3B. The stock trades 4.84% below GF Value estimate.
How this was made
The 30-second read
Why it matters
Analyst target raise reflects confidence in infrastructure strength, yet the stock's dip highlights market caution.
Market read
IBM’s share price moved down 1% despite a significant target increase, indicating mixed market reaction.
What to watch
Potential headwinds from soft consulting demand and dividend payout pressure could limit upside.
Background
IBM reported Q2 free cash flow of $2.5 bn, $1.6 bn paid as dividends, and mixed revenue growth (software up 5%, consulting flat).
Ticker impact
Morgan Stanley raised its price target for IBM to $238 from $190, a 25% increase, while the stock fell about 1% intraday.
likely modest downside pressure as the market digests the target lift amid a small price decline.
Analyst target upgrades usually support the stock, but the current sell‑off indicates investors may be skeptical or awaiting further guidance.
Market effects
The upgrade may lift sentiment in the broader enterprise‑software and AI‑services sector.
Primarily U.S. market impact; limited effect on other regions.
Modest relevance as IBM is a large cap with global exposure.
Counterpoint
The price target increase may be premature given flat consulting revenue and modest cash generation.
Key entities
- AnalystMorgan Stanley
Raised IBM price target to $238.
